This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Gc Cell Corporation. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Eunji Choi: Innovator in Cancer Treatment
Introduction
Eunji Choi is a prominent inventor based in Yongin-si, South Korea. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel antibodies.
Latest Patents
Eunji Choi holds three patents, with her latest inventions focusing on an anti-HER2 antibody and a chimeric antigen receptor. These patents relate to a novel anti-HER2 antibody or an antigen-binding fragment that is utilized in the prevention or treatment of cancer. The antibody specifically binds to HER2, which is highly expressed in cancer cells, particularly in breast and gastric cancer. This antibody targets an epitope distinct from the one that trastuzumab binds to, offering a new approach to cancer therapy.
Career Highlights
Eunji Choi is currently associated with Gc Cell Corporation, where she continues her groundbreaking work in cancer research. Her dedication to developing effective treatments has positioned her as a key figure in the biotechnology industry.
Collaborations
Eunji collaborates with notable colleagues, including Jong Seo Lee and Kyu Tae Kim, who contribute to her research efforts and innovations.
Conclusion
Eunji Choi's work in developing novel anti-HER2 antibodies represents a significant advancement in cancer treatment. Her contributions are paving the way for new therapeutic options for patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile